Tuesday, March 10, 2020 - Activists in the LGBTQ community have sounded the alarm that lawyers and others were running misleading ads on Facebook that overstated the potential adverse side effects of TDF drugs like Truvada and frightening people away from taking the drug for pre-exposure prophylactic purposes. In response, Facebook pulled many ads that failed to make a distinction between those who take the drug to manage their HIV condition, and those that take the drug before having sex to attempt to remain HIV negative. The group's objections to the ads are valid to the extent that HIV positive users of the drug may experience more intense and potentially life-threatening side effects as a result of having an HIV-compromised immune system, to begin with. On the other hand, people who are contemplating using drugs like Truvada for the first time as part of the Government's PrEP drug giveaway should be aware of the suffering of many others who have taken Truvada and that the drug's manufacturer, Gilead Science has been accused of fraudulently misleading the public. Among many accusations, it has been alleged that Gilead had a safer and more effective HIV management drug in their back pocket, Descovy, for years and kept it off of the market to maximize their profits until Truvada's patent expired this year. No matter what reason you have for taking TDF drugs people have a right to know about the drug's side effects to help them make an informed decision. Truvada lawyers offer a free consultation to all people harmed from Truvada medication which is known to cause brittle and broken bones, kidney failure and work on a contingency basis.
Truvada is a drug that treats and prevents HIV and AIDS by combining emtricitabine and tenofovir disoproxil fumarate (TDF) and prevents HIV cells from multiplying, making it effective in treating those with AIDS. The National Institute for Health (NIF) describes TDF drug Tenofovir DF as belonging "to a group of HIV drugs called nucleoside reverse transcriptase inhibitors (NRTIs). NRTIs block an HIV enzyme called reverse transcriptase. By blocking reverse transcriptase, NRTIs prevent HIV from multiplying and can reduce the amount of HIV in the body."
Lawsuits have been filed that allege Gilead Sciences withheld tenofovir alafenamide (TAF) to maximize the $2000 per month per patient income from overcharging for the drug. The US Department of Health and Human Services (HHS) lists the potential side effects of taking TDF drugs that apply to those who use the drug for prophylactic measures as well as to those who use it to treat their HIV condition. "Tenofovir disoproxil fumarate (tenofovir DF) can cause serious, life-threatening side effects. These include a buildup of lactic acid in the blood (lactic acidosis), severe liver problems, and new or worsening kidney problems, including kidney failure." Indications that you could be experiencing kidney damage could include, "yellowing of your skin or the whites of your eyes (jaundice), dark-colored urine, light-colored bowel movements, loss of appetite for several days or longer, nausea, and stomach pain."
OnderLaw, LLC is a St. Louis personal injury law firm handling serious injury and death claims across the country. Its mission is the pursuit of justice, no matter how complex the case or strenuous the effort. The Onder Law Firm has represented clients throughout the United States in pharmaceutical and medical device litigation such as Pradaxa, Lexapro and Yasmin/Yaz, where the firm's attorneys held significant leadership roles in the litigation, as well as Actos, DePuy, Risperdal and others. The firm has represented thousands of persons in these and other products liability litigation, including DePuy hip replacement systems, which settled for $2.5 billion and Pradaxa internal bleeding, which settled for $650 million. The Onder Law Firm won over $300 million in four talcum powder ovarian cancer lawsuits in St. Louis to date and other law firms throughout the nation often seek its experience and expertise on complex litigation.